Form D · Biotechnology
Cavion, Inc.
Charlottesville, VA · CIK 0001348076
Offering snapshot reported Jan 12, 2017 · SEC filing
- Reported sold
- $22.3M Offering amount: $31.5M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 28, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2017 | Initial | $22,312,867 | No comparison | 19 | SEC filing |
| Jun 10, 2014 | Amendment | $12,837,500 | $3,550,000vs Jan 15, 2013 | 54 | SEC filing |
| Jan 15, 2013 | Amendment | $9,287,500 | No comparison | 50 | SEC filing |
| Nov 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 2, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-278301
Offer and sale of shares of preferred stock and the underlying shares of common stock issuable upon conversion thereof; conversion of notes and the underlying shares of common stock issuable upon conversion thereof.
Source: Form D, filed Jan 12, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David E Gibson | Director |
| Lloyd Gray | Executive |
| Steve Hall | Director |
| Anne Heldreth | Executive |
| Andrew J Krouse | Director, Executive |
| Timothy Macdonald | Executive |
| Sergei Petukhov | Director |
| Henry Skinner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
600 East Water Street, Suite E
Charlottesville, VA, 22902
Charlottesville, VA, 22902